Published in Am J Respir Crit Care Med on November 01, 2000
Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care (2006) 3.19
Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest (2006) 2.29
TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res (2010) 2.14
Resilience to bacterial infection: difference between species could be due to proteins in serum. J Infect Dis (2010) 1.73
Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock (2008) 1.48
NF-κB in Aging and Disease. Aging Dis (2011) 1.28
Clinical review: extracorporeal blood purification in severe sepsis. Crit Care (2003) 1.23
Extrinsic and intrinsic control of macrophage inflammatory responses. J Leukoc Biol (2013) 1.23
The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants. Shock (2013) 1.12
Nuclear factor kB activity in patients with acute severe cholangitis. World J Gastroenterol (2002) 1.09
Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care (2005) 1.08
TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses. Blood (2013) 1.06
Tolerance induced via TLR2 and TLR4 in human dendritic cells: role of IRAK-1. BMC Immunol (2008) 0.97
Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population. PLoS One (2013) 0.94
IRAK-M regulates chromatin remodeling in lung macrophages during experimental sepsis. PLoS One (2010) 0.93
Activation of nuclear factor kappa B in peripheral blood mononuclear cells from malaria patients. Malar J (2012) 0.88
Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice. Infect Immun (2001) 0.88
CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases. J Biol Chem (2008) 0.88
Pro/con clinical debate: is high-volume hemofiltration beneficial in the treatment of septic shock? Crit Care (2002) 0.87
Sickness behaviour pushed too far--the basis of the syndrome seen in severe protozoal, bacterial and viral diseases and post-trauma. Malar J (2008) 0.87
Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: views over hidden possibilities. AIDS Res Ther (2007) 0.85
Phenotype and functions of natural killer cells in critically-ill septic patients. PLoS One (2012) 0.84
Role of NF-kB in multiple organ dysfunction during acute obstructive cholangitis. World J Gastroenterol (2003) 0.83
Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate. Expert Opin Investig Drugs (2009) 0.82
Tumour necrosis factor-α plus interleukin-10 low producer phenotype predicts acute kidney injury and death in intensive care unit patients. Clin Exp Immunol (2013) 0.80
Analysis of NF-kappaB nuclear translocation in PMN-neutrophils of major trauma patients in the early post-traumatic period: a pilot study. World J Surg (2006) 0.79
Effect of pulsed electromagnetic field on inflammatory pathway markers in RAW 264.7 murine macrophages. J Inflamm Res (2013) 0.78
Does cardiac surgery in newborn infants compromise blood cell reactivity to endotoxin? Crit Care (2005) 0.78
p21 mediates macrophage reprogramming through regulation of p50-p50 NF-κB and IFN-β. J Clin Invest (2016) 0.77
Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance. J Biol Chem (2015) 0.77
Effect of malaria components on blood mononuclear cells involved in immune response. Asian Pac J Trop Biomed (2013) 0.77
Correlation between nuclear factor κB activity and pulmonary artery pressure in a rat high pulmonary blood flow model. Exp Ther Med (2014) 0.75
The role of indoleamine 2,3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs. Sci Rep (2017) 0.75
Structure-Dependent Immune Modulatory Activity of Protegrin-1 Analogs. Antibiotics (Basel) (2014) 0.75
Impaired blood dendritic cell numbers and functions after aneurysmal subarachnoid hemorrhage. PLoS One (2013) 0.75
When host defense goes awry: Modeling sepsis-induced immunosuppression. Drug Discov Today Dis Models (2012) 0.75
Effect of nucleoprotein factor-kB (NF-κB) in endothelial cells during high blood flow-associated pulmonary vascular remodeling on vasoactive substances adrenomedullin and prostacyclin. Int J Clin Exp Med (2015) 0.75
Pro-Resolving Molecules-New Approaches to Treat Sepsis? Int J Mol Sci (2017) 0.75
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med (2000) 5.53
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86
Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med (2001) 3.98
Half the families of intensive care unit patients experience inadequate communication with physicians. Crit Care Med (2000) 3.78
Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest (1991) 3.62
Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med (1997) 3.53
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA (1999) 3.51
Long-term outcome of critically ill elderly patients requiring intensive care. JAMA (1993) 3.27
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84
Iatrogenic complications in adult intensive care units: a prospective two-center study. Crit Care Med (1993) 2.84
Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med (1994) 2.53
Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J Clin Invest (1994) 2.47
French intensivists do not apply American recommendations regarding decisions to forgo life-sustaining therapy. Crit Care Med (2001) 2.39
Clinical use of respiratory changes in arterial pulse pressure to monitor the hemodynamic effects of PEEP. Am J Respir Crit Care Med (1999) 2.28
Is the pulmonary artery catheter misused? A European view. Crit Care Med (1998) 2.23
Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med (2001) 2.18
Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med (1998) 2.14
Strong ion gap: a methodology for exploring unexplained anions. J Crit Care (1995) 2.09
Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med (1998) 2.05
Effect of intrathoracic pressure on left ventricular performance. N Engl J Med (1979) 2.01
Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med (1994) 2.01
Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun (1990) 1.74
The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med (1998) 1.71
Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study. Intensive Care Med (1998) 1.71
Propofol versus sevoflurane for fiberoptic intubation under spontaneous breathing anesthesia in patients difficult to intubate. Minerva Anestesiol (2010) 1.70
Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest (1995) 1.67
Release of lactate by the lung in acute lung injury. Chest (1997) 1.66
Quantifying learning in medical students during a critical care medicine elective: a comparison of three evaluation instruments. Crit Care Med (2001) 1.65
Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med (2000) 1.62
Estimating cardiac filling pressure in mechanically ventilated patients with hyperinflation. Crit Care Med (2000) 1.57
THE GROWTH OF NEISSERIA MENINGITIDIS IN SIMPLE CHEMICALLY DEFINED MEDIA. J Bacteriol (1949) 1.56
Noninvasive cardiac output monitoring by aortic blood flow determination: evaluation of the Sometec Dynemo-3000 system. Crit Care Med (1998) 1.56
Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med (1996) 1.55
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med (1995) 1.54
Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem (1996) 1.54
Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. Am J Respir Crit Care Med (1999) 1.53
Meeting the needs of intensive care unit patient families: a multicenter study. Am J Respir Crit Care Med (2001) 1.52
Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol (1991) 1.46
Assessment of left ventricular contractile state by preload-adjusted maximal power using echocardiographic automated border detection. J Am Coll Cardiol (1998) 1.45
Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation (1987) 1.44
Defining the hypoxic threshold. Crit Care Med (1991) 1.44
Quantitative assessment of alterations in regional left ventricular contractility with color-coded tissue Doppler echocardiography. Comparison with sonomicrometry and pressure-volume relations. Circulation (1997) 1.43
Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg (1992) 1.42
Reprogramming of circulatory cells in sepsis and SIRS. J Endotoxin Res (2005) 1.42
Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med (2001) 1.41
Short-term effect of inhaled nitric oxide and prone positioning on gas exchange in patients with severe acute respiratory distress syndrome. Crit Care Med (2000) 1.39
A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol (1994) 1.39
Respiratory sinus arrhythmia in the denervated human heart. J Appl Physiol (1985) (1989) 1.39
Lack of efficacy of inhaled nitric oxide in ARDS. Intensive Care Med (1994) 1.38
Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun (1994) 1.37
The effect of managed care on ICU length of stay: implications for medicare. JAMA (1996) 1.35
LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med (1999) 1.35
The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med (1998) 1.32
Reproducibility of thermodilution cardiac output determination in critically ill patients: comparison between bolus and continuous method. J Clin Monit (1996) 1.28
Compliance with triage to intensive care recommendations. Crit Care Med (2001) 1.28
Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J (1999) 1.27
Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock (1998) 1.25
Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin. Mol Immunol (1986) 1.24
Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol (1990) 1.23
Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med (1993) 1.22
The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med (2000) 1.22
Determinants of pulmonary arterial flow variation during respiration. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.20
Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains. Antimicrob Agents Chemother (1996) 1.20
Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res (1996) 1.19
Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc (1987) 1.17
Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice. Antimicrob Agents Chemother (2000) 1.16
Molecular requirement for interleukin 1 induction by lipopolysaccharide-stimulated human monocytes: involvement of the heptosyl-2-keto-3-deoxyoctulosonate region. Eur J Immunol (1986) 1.15
Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care (1993) 1.15
Instantaneous venous return curves in an intact canine preparation. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.15
Short-term and long-term outcome prediction with the Acute Physiology and Chronic Health Evaluation II system after orthotopic liver transplantation. Crit Care Med (2000) 1.14
Circulating cytokines: the tip of the iceberg? Circ Shock (1992) 1.13
Lipopolysaccharide receptor on rabbit peritoneal macrophages. I. Binding characteristics. J Immunol (1982) 1.12
Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med (2000) 1.12
Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ Res (1997) 1.12
Interleukin 1 secretion by human monocytes stimulated by the isolated polysaccharide region of the Bordetella pertussis endotoxin. Mol Immunol (1984) 1.11
Current understanding of sepsis. Clin Infect Dis (1996) 1.10
Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect Immun (2000) 1.10
C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol (1987) 1.10
L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues. AIDS (2000) 1.10
Medical students can learn the basic application, analytic, evaluative, and psychomotor skills of critical care medicine. Crit Care Med (2000) 1.09
Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J Endotoxin Res (2001) 1.09
Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect Immun (1999) 1.08
The inflammatory balance in human sepsis. Intensive Care Med (2000) 1.08
Technology comparison studies require precise reference controls to be valid. Br J Anaesth (2013) 1.07